1. Home
  2. METCB vs PHAR Comparison

METCB vs PHAR Comparison

Compare METCB & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • METCB
  • PHAR
  • Stock Information
  • Founded
  • METCB 2015
  • PHAR 1988
  • Country
  • METCB United States
  • PHAR Netherlands
  • Employees
  • METCB N/A
  • PHAR N/A
  • Industry
  • METCB Coal Mining
  • PHAR Biotechnology: Pharmaceutical Preparations
  • Sector
  • METCB Energy
  • PHAR Health Care
  • Exchange
  • METCB Nasdaq
  • PHAR Nasdaq
  • Market Cap
  • METCB 531.6M
  • PHAR 627.5M
  • IPO Year
  • METCB N/A
  • PHAR N/A
  • Fundamental
  • Price
  • METCB $9.39
  • PHAR $9.10
  • Analyst Decision
  • METCB Strong Buy
  • PHAR Strong Buy
  • Analyst Count
  • METCB 3
  • PHAR 3
  • Target Price
  • METCB $19.67
  • PHAR $27.00
  • AVG Volume (30 Days)
  • METCB 61.7K
  • PHAR 7.3K
  • Earning Date
  • METCB 11-04-2024
  • PHAR 10-24-2024
  • Dividend Yield
  • METCB 9.37%
  • PHAR N/A
  • EPS Growth
  • METCB N/A
  • PHAR N/A
  • EPS
  • METCB 0.71
  • PHAR N/A
  • Revenue
  • METCB $698,132,000.00
  • PHAR $285,745,000.00
  • Revenue This Year
  • METCB N/A
  • PHAR $20.89
  • Revenue Next Year
  • METCB $20.44
  • PHAR $11.15
  • P/E Ratio
  • METCB $15.53
  • PHAR N/A
  • Revenue Growth
  • METCB 11.52
  • PHAR 30.64
  • 52 Week Low
  • METCB $9.21
  • PHAR $6.65
  • 52 Week High
  • METCB $13.97
  • PHAR $13.20
  • Technical
  • Relative Strength Index (RSI)
  • METCB 40.37
  • PHAR 61.21
  • Support Level
  • METCB $9.70
  • PHAR $8.24
  • Resistance Level
  • METCB $10.46
  • PHAR $9.59
  • Average True Range (ATR)
  • METCB 0.64
  • PHAR 0.35
  • MACD
  • METCB -0.06
  • PHAR 0.10
  • Stochastic Oscillator
  • METCB 0.00
  • PHAR 76.89

About METCB Ramaco Resources Inc. Class B

Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves and resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mill and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. Operations are concentrated in the Appalachian basin, with active mines at Elk Creek, Berwind, Knox Creek, and Maben mining complexes.

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

Share on Social Networks: